Graham Steell murmur is a high-pitched, blowing, decrescendo early diastolic murmur caused by relative (functional) pulmonary regurgitation in the setting of severe pulmonary hypertension and marked dilation of the pulmonary valve annulus 1. Originally described by British physician Graham Steell in 1888 in patients with mitral stenosis, this auscultatory finding signifies elevated pulmonary artery pressures that render the pulmonary valve leaflets incapable of normal coaptation during diastole 1. Although less common in the modern era of early intervention for valvular and congenital heart disease, recognizing this clinical sign remains critical for identifying advanced pulmonary vascular or left-sided heart pathology that threatens right ventricular function.

Etiology & Risk Factors

  • Rheumatic Mitral Stenosis: Historically the classic association, where chronic elevation of left atrial pressure transmits backward into the pulmonary circulation, causing fixed pulmonary arterial hypertension and subsequent pulmonary annular dilation 1.
  • Idiopathic Pulmonary Arterial Hypertension (PAH / Group 1 PH): Severe obliterative pulmonary vasculopathy resulting in marked right ventricular systolic pressure elevation and subsequent pulmonary trunk expansion.
  • Left Heart Disease (Group 2 PH): Heart failure with preserved ejection fraction (HFpEF) or reduced ejection fraction (HFrEF) accompanied by chronic post-capillary pulmonary hypertension.
  • Chronic Lung Disease & Hypoxia (Group 3 PH): Advanced chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis, or obstructive sleep apnea leading to hypoxic pulmonary vasoconstriction and vascular remodeling.
  • Chronic Thromboembolic Pulmonary Hypertension (CTEph / Group 4 PH): Unresolved pulmonary emboli causing mechanical obstruction of the pulmonary vascular bed and sustained high afterload.
  • Congenital Heart Disease: Large left-to-right shunts (e.g., ventricular septal defect, patent ductus arteriosus, or truncus arteriosus) resulting in Eisenmenger syndrome and irreversible pulmonary vascular disease.

Pathophysiology

The pathogenesis of the Graham Steell murmur is fundamentally haemodynamic and structural. When pulmonary arterial pressure rises chronically, the main pulmonary artery and the pulmonary valve ring undergo significant mechanical dilatation. The pulmonary valve leaflets, which are structurally normal and free of intrinsic pathology such as endocarditis or myxomatous degeneration, stretch across an expanded perimeter. During ventricular diastole, as right ventricular pressure drops below the elevated pressure of the pulmonary trunk, the stretched valve ring prevents the leaflets from meeting fully in the center. This incomplete coaptation creates a central orifice through which a high-velocity, high-pressure jet of blood regurgitates from the pulmonary artery back into the right ventricle. The high pressure gradient combined with the narrow regurgitant orifice generates high-frequency vibrations that manifest clinically as a high-pitched, soft, early diastolic decrescendo murmur. Over time, chronic volume overload from the regurgitant fraction contributes to right ventricular dilation, tricuspid annular stretching, secondary functional tricuspid regurgitation, and progressive right heart failure.

Graham Steell murmur — Pathophysiological Cascade & Clinical Flowchart 1 Primary Insult Severe chronic pulmonary hypertension or mitral stenosis leading to massive dilation of the pulmonary trunk and ring. 2 Pathophysiological Cascade Geometric annular stretching prevents complete coaptation of the pulmonary valve leaflets during diastole. 3 Target Organ Change Diastolic backflow of blood from the high-pressure pulmonary artery into the right ventricle under low pressure. 4 Clinical Manifestation Generation of a high-frequency, decrescendo early diastolic murmur best heard along the left second and third intercostal spaces. 5 Therapeutic Target Reduction of pulmonary vascular resistance and right ventricular afterload via targeted medical or surgical intervention.

Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Patients typically present with symptoms of underlying advanced cardiopulmonary disease. Progressive exertional dyspnoea is universal. Other prominent symptoms include fatigue, effort-induced lightheadedness, exertional chest pain due to right ventricular subendocardial ischemia, peripheral edema, and abdominal fullness caused by congestive hepatomegaly.
  • Physical Examination & Named Clinical Signs:
    • Auscultation: A high-pitched, blowing, decrescendo diastolic murmur heard best at the left sternal border (second and third intercostal spaces). The murmur characteristically increases in intensity during inspiration (Carvallo sign for right-sided murmurs, though pulmonary valve murmurs can sometimes exhibit variable respiratory modulation). It is frequently accompanied by a loud pulmonary component of the second heart sound (P2) and a palpable pulmonary tap.
    • Inspection and Palpation: A parasternal heave or lift reflecting right ventricular hypertrophy and enlargement. Jugular venous pressure (JVP) is typically elevated, often demonstrating prominent "a" waves (in the presence of sinus rhythm and pulmonary hypertension) or prominent "v" waves if significant secondary tricuspid regurgitation is present.
    • Extremities: Cyanosis, clubbing (in congenital aetiologies), and peripheral pitting edema in advanced right ventricular failure.

Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationTransthoracic Echocardiography (TTE) with color Doppler demonstrating main pulmonary artery dilation, a high-velocity pulmonary regurgitation jet, and an estimated elevated pulmonary artery systolic pressure (>40–50 mmHg); confirmed by right heart catheterization showing mean pulmonary artery pressure >20 mmHg and normal pulmonary capillary wedge pressure (in pre-capillary forms).
Laboratory PanelElevated natriuretic peptides (NT-proBNP or BNP) reflecting right ventricular wall stress; renal function panel and liver function tests displaying congestion-related impairment (elevated bilirubin, transaminases, and creatinine).
Imaging / Radiology (X-ray, US, CT, MRI)Chest radiography revealing marked enlargement of the main pulmonary artery segment, pruning of peripheral pulmonary vessels, and right ventricular silhouette enlargement. Chest CT angiography evaluates for pulmonary thromboembolic disease and lung parenchymal architecture. Cardiac MRI provides precise quantification of right ventricular volumes, ejection fraction, and pulmonary regurgitant fraction.
ECG / Histopathology / ProceduralElectrocardiogram showing right axis deviation, tall R waves in V1-V3, ST-T wave abnormalities in the right precordial leads (strain pattern), and incomplete or complete right bundle branch block. Histopathology of pulmonary vasculature (if biopsied) reveals medial hypertrophy, intimal fibrosis, and plexiform lesions in severe pulmonary arterial hypertension.

Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
WHO Functional Classification of Pulmonary HypertensionClass I: No limitation of physical activity. Class II: Slight limitation, comfortable at rest. Class III: Marked limitation, comfortable only at rest. Class IV: Inability to carry out any physical activity with symptoms at rest; indicates severe hemodynamic compromise and need for advanced therapy.
REVEAL Risk Score (Lite 2)Assesses 1-year mortality risk in pulmonary arterial hypertension using parameters such as renal function, BNP/NT-proBNP, functional class, blood pressure, heart rate, and imaging findings; guides escalation to combination medical therapy.

Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Aortic RegurgitationDiastolic murmur heard best at the left sternal border or aortic area radiating down the left sternal edge, but accompanied by peripheral vascular signs of wide pulse pressure (e.g., Corrigan pulse, de Musset sign, water-hammer pulse). Echocardiography confirms aortic valve leaflet pathology rather than a normal valve with high-pressure pulmonary regurgitation.
Austin Flint MurmurMid-to-late diastolic rumble heard at the apex in severe aortic regurgitation, caused by the regurgitant jet impeding mitral valve opening. Distinguished from Graham Steell by its location at the apex and association with an aortic origin.
Carey Coombs MurmurShort mid-diastolic apical murmur heard in active acute rheumatic carditis associated with inflamed mitral leaflets, lacking pulmonary hypertension signs.
Functional Tricuspid Stenosis MurmurMid-diastolic murmur heard along the left lower sternal border in massive tricuspid regurgitation, intensifying markedly during inspiration, but associated with severe right atrial enlargement.

Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Assess oxygenation and provide supplemental oxygen if hypoxemic to reduce hypoxic pulmonary vasoconstriction. Ensure hemodynamic stability and monitor fluid balance strictly to prevent worsening right ventricular failure.
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing):
    • Diuresis: Loop diuretics (e.g., furosemide 20–40 mg IV/oral daily, titrated up to 80–120 mg daily as needed) to manage systemic and hepatic congestion and lower right ventricular filling pressures.
    • Specific Pulmonary Arterial Hypertension Therapies (for Group 1 PAH): Phosphodiesterase-5 inhibitors (e.g., sildenafil 20 mg orally three times daily or tadalafil 40 mg orally once daily), endothelin receptor antagonists (e.g., ambrisentan 5 mg to 10 mg orally once daily, or macitentan 10 mg orally once daily), and prostacyclin pathway agonists.
    • Underlying Cause Management: Guideline-directed medical therapy for heart failure with reduced ejection fraction (ARNI/ACEi/ARB, beta-blockers, mineralocorticoid receptor antagonists, SGLT2 inhibitors) when post-capillary pulmonary hypertension is present.
  • Surgical / Interventional Indications: Treatment focuses primarily on reducing pulmonary vascular resistance. In select cases of thromboembolic pulmonary hypertension, pulmonary endarterectomy or balloon pulmonary angioplasty is indicated. Valve surgery (replacement or repair) for the pulmonary valve is rarely indicated for a Graham Steell murmur unless severe right ventricular failure persists despite optimization of pulmonary pressures, or in the presence of structural valve destruction (e.g., endocarditis). Lung or heart-lung transplantation is reserved for end-stage, refractory World Health Organization Functional Class IV pulmonary arterial hypertension.

Complications & Prognosis

  • Complications: Progressive right ventricular dilation and failure (cor pulmonale), tricuspid annular dilation leading to severe functional tricuspid regurgitation, systemic venous congestion resulting in cardiac cirrhosis and congestive nephropathy, atrial arrhythmias (such as atrial fibrillation or flutter), and sudden cardiac death due to electromechanical dissociation or malignant ventricular arrhythmias.
  • Prognosis: The presence of a Graham Steell murmur indicates severe, longstanding pulmonary hypertension and carries a guarded prognosis, as it correlates directly with advanced right ventricular afterload and dysfunction. Long-term outcomes depend heavily on the reversibility and management of the underlying primary pathology (e.g., response to targeted PAH pharmacotherapy, successful mitral valve intervention, or treatment of chronic thromboembolism) 1,3.